December 13, 2010 -- Steve Yang, PhD, who has been Pfizer’s highly visible Vice-President for Asia R&D, will join AstraZeneca, taking on the same duties. In China, Pfizer has had one of the more innovative pharma business models, with great autonomy to pursue deals and make alliances. Both companies will be watched to see how their business models develop after Dr. Yang leaves Pfizer to assumes his new position at AstraZeneca on January 1, 2011. More details....
